Intco Medical Technology Co., Ltd. Stock: price and insider trades · China
英科医疗
No insider purchase over the last 90 days. The latest, by 刘方毅, was filed 22 Mar 2024.
Since the insiders bought
- +15.0%Entry CN¥21.03 · Close at T+365 CN¥24.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 121,000 shares1.1% of flowA股XSHESZSE:173000007417101060Canonical exit: 20 Jun 2024 (T+90)
- 2,242,050 shares55.1% of flowA股XSHESZSE:173000005069817150
- 10,000 shares32.6% of flowA股XSHESZSE:173000005688670140
- 63,000 shares2.8% of flowA股XSHESZSE:173000004609545250
- 547,163 shares23.2% of flowA股XSHESZSE:173000004609545200
- 40,400 shares100.0% of flowA股XSHESZSE:173000004604146300
- 345,650 shares17.9% of flowA股XSHESZSE:173000004569030100
- 10,000 shares34.2% of flowA股XSHESZSE:173000004568925820
- 10,000 shares33.2% of flowA股XSHESZSE:173000004560489280
- 18,000 shares100.0% of flowA股XSHESZSE:173000004904274780
10 of 10 declarations
About Intco Medical Technology Co., Ltd.
英科医疗 (Intco Medical Technology Co., Ltd.), a Chinese health care company valued at CNY 29.2 billion and 35.7% held by its insiders, has a record compressed into 2021: 9 of its 10 filings, published between July 9, 2021 and March 22, 2024, are sales worth EUR 31.5 million in total (median EUR 531,816).
The filer 刘方毅, listed as 董事长 for the sales, is behind the three largest amounts: EUR 16,815,429 on November 12, 2021, EUR 7,091,386 on July 29, 2021 and EUR 5,455,284 on July 16, 2021. The record closes with its only purchase, EUR 330,061, filed under the same name, this time as 董事, on March 22, 2024. 刘方毅 totals 5 filings, 1 purchase and 4 sales. 陈琼 (董事,总经理) has 3, all sales.
Read moreShow less
Purchases weigh only 10% of open-market trades. 李斌 (副总经理,董事会秘书) and 于海生 (董事,高管) each filed one sale. The median publication delay is 0 days and no filing falls within the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
